A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?

Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.

By Stephanie Nolen and Arlette Bashizi